Literature DB >> 8637575

Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits.

S R Ikeda1.   

Abstract

The most commonly used signal transduction pathway for receptor-mediated N-type Ca2+-channel modulation involves activation of a heterotrimeric G protein to produce voltage-dependent inhibition. Although it is widely assumed that Galpha mediates this effect, experiments to address this hypothesis directly are lacking. Here I show that transient overexpression of Gbetagamma in sympathetic neurons mimics and occludes the voltage-dependent Ca2+ channel modulation produced by noradrenaline (NA). Conversely, over-expression of Galpha produces minimal effects on basal Ca2+ channel behaviour but attenuates NA-mediated inhibition in a manner consistent with the buffering of Gbetagamma. These observations indicate that it is Gbetagamma, and Galpha, that mediates voltage-dependent inhibition of N-type Ca2+ channels. The identification of Gbetagamma as the mediator of this pathway has broad implications as G-protein-coupled receptors, many of which are implicated in disease or are targets of therapeutic agents, couple to N-type Ca2+ channels and may modulate synaptic transmission by this mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8637575     DOI: 10.1038/380255a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  307 in total

1.  Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures.

Authors:  E M Blalock; N M Porter; P W Landfield
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Involvement of both G protein alphas and beta gamma subunits in beta-adrenergic stimulation of vascular L-type Ca(2+) channels.

Authors:  P Viard; N Macrez; C Mironneau; J Mironneau
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits.

Authors:  S Herlitze; H Zhong; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  Control of gating mode by a single amino acid residue in transmembrane segment IS3 of the N-type Ca2+ channel.

Authors:  H Zhong; B Li; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Biphasic, opposing modulation of cloned neuronal alpha1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors.

Authors:  U Meza; R Bannister; K Melliti; B Adams
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

6.  Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma.

Authors:  C Cantí; K M Page; G J Stephens; A C Dolphin
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

7.  Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

8.  betagamma dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurones.

Authors:  P Delmas; F C Abogadie; G Milligan; N J Buckley; D A Brown
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

9.  Multiple G-protein betagamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons.

Authors:  V Ruiz-Velasco; S R Ikeda
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

10.  Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits inhibits Ca(2+) current in sympathetic neurons.

Authors:  A K Filippov; A Couve; M N Pangalos; F S Walsh; D A Brown; S J Moss
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.